Skip to main content

Aerpio Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference

Aerpio Pharmaceuticals, Inc. (OTCQB:ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, today announced that Chief Executive Officer, Stephen Hoffman, M.D., Ph.D., will present at the Jefferies 2018 Global Healthcare Conference on Friday, June 8, 2018 at 1:30 p.m. Eastern Time in New York, NY. Dr. Hoffmann will provide a corporate overview and business update.

The presentation will be webcast live and may be accessed by visiting Aerpio's website at http://ir.aerpio.com/.

About Aerpio Pharmaceuticals

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company’s lead compound, AKB‐9778, is a small molecule activator of the Tie2 pathway and is in clinical development for the treatment of non-proliferative diabetic retinopathy. For more information please visit www.aerpio.com.

Contacts:

Aerpio Pharmaceuticals, Inc.
Michael Rogers, 513-985-1958
Chief Financial Officer

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.